Clinical Trial Analysis

Know whether your trial can recruit, and what it will cost, before you commit.

Independent analysis of clinical protocols, site feasibility, and study economics—with transparent evidence and assumptions.

Protocol Review

Feasibility & Sites

Budgeting & Economics

Where Planning Goes Wrong

Most trial plans rest on assumptions no one has written down.

01

The protocol is harder to recruit than it looks.

Narrow diagnosis windows, strict screening thresholds, and demanding visit schedules shrink the real patient pool well below the headline population.

02

The budget rests on allowances no one has checked.

Overlapping line items, unpriced components, and flat monthly estimates can hide what actually drives cost until a vendor or site proposal arrives.

03

The site list is a guess.

A registry listing or a strong reputation doesn't show eligible-patient volume, competing trials, or whether a site has the capacity to deliver.

We make those assumptions explicit, quantify them, and show which ones to verify first.

Book a scoping call

Services

Three ways we reduce planning risk.

Study-specific analysis, delivered as actionable reports with a walkthrough.

Protocol & Eligibility Review

Review of study design, eligibility criteria, and endpoints to identify recruitment and analysis risks.

  • Eligibility and criteria review
  • Design and analysis considerations
  • Sources and evidence gaps

Identify protocol risks early.

Feasibility & Site Assessment

Patient-pool estimates, competing-trial analysis, and evidence-based site evaluation.

  • Enrollment and screening scenarios
  • Competing-study analysis
  • Site profiles and shortlist

Establish a defensible enrollment range.

Study Budgeting & Healthcare Economics

Scenario-based study budgets, cost reconciliation, and review of CRO and site proposals.

  • Fixed, site, participant, and recurring costs
  • Low, base, and high scenarios
  • Cost overlap and gap analysis

Build a budget you can defend and negotiate.

AlsoEnrollment forecastingCompetitive trial analysisInvestor & partner diligenceCustom analytical tools
Book a scoping call

How It Works

A clear process, grounded in evidence.

  1. 01

    Scoping call

    Define the study, key decisions, scope, and required materials.

  2. 02

    Analysis

    Evaluate protocols, sites, enrollment, and costs using documented evidence and explicit assumptions.

  3. 03

    Delivery

    Receive a client-ready report, walkthrough, and prioritized next steps.

Evidence levels

Every figure is classified by its supporting evidence, distinguishing verified facts from estimates and assumptions.

A
Confirmed
Verified with a site or primary source.
B
Documented
Supported by a public primary source.
C
Estimated
Calculated from stated inputs and methods.
D
Assumed
Scenario input without direct evidence.

About

Sophie Choe, Ph.D.

Founder & CEO, Clinovia.ai

Adjunct Assistant Professor
The University of Texas at Dallas

I'm a quantitative scientist who helps clinical development teams evaluate their plans before they commit to them. My training is in mathematics and engineering, with a PhD in electrical and computer engineering focused on quantum machine learning. I also serve as an Adjunct Assistant Professor at UT Dallas, where my academic work includes healthcare AI.

Developing machine-learning models to predict progression from mild cognitive impairment to Alzheimer's disease gave me practical experience working with clinical outcomes, patient characteristics, longitudinal data, and predictive uncertainty. I bring that analytical discipline to clinical protocol review, feasibility assessment, and study economics. My work connects evidence, assumptions, and quantitative analysis to the decisions sponsors need to make.

Where the data and intended use justify it, I also develop predictive models for trial enrichment and prescreening. Across all engagements, I emphasize transparent assumptions, traceable evidence, and analysis that is useful for real-world decisions.

Our analysis supports your team's decisions. It does not replace protocol, biostatistical, medical, or regulatory review.

Book a scoping call

Contact

Tell us the decision you need to make.

A scoping call is 30 minutes. We'll discuss your study, the question behind it, and whether an analysis would help. There's no obligation.

Prefer email? hello@clinovia.com

Please don't include confidential protocol details in this first message. We'll use what you send only to respond to your inquiry.